Evidence map›Paper›PMID 37046699›Full record

ArticleCancers2023

Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer-An Analysis of the NOGGO/JAGO.

Sabine Heublein, Joanna Baum, Anna Jaeger, Donata Grimm-Glang, Julia Olthoff, Elena Ioana Braicu, Osama Azzam Nieto, Kathrin Hassdenteufel, Barbara Schmalfeldt, Lars Hanker and 4 more

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sabine HeubleinDepartment of Gynecology and Obstetrics, University of Heidelberg, 69120 Heidelberg, Germany.
Joanna BaumYoung Academy of Gynecologic Oncology (JAGO), 13359 Berlin, Germany.
Anna JaegerYoung Academy of Gynecologic Oncology (JAGO), 13359 Berlin, Germany.ORCID 0000-0001-8833-0618
Donata Grimm-GlangYoung Academy of Gynecologic Oncology (JAGO), 13359 Berlin, Germany.
Julia OlthoffYoung Academy of Gynecologic Oncology (JAGO), 13359 Berlin, Germany.
Elena Ioana BraicuDepartment of Gynecology, Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 13353 Berlin, Germany.
Osama Azzam NietoDepartment of Gynecology and Obstetrics, University of Heidelberg, 69120 Heidelberg, Germany.
Kathrin HassdenteufelDepartment of Gynecology and Obstetrics, University of Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0003-0141-7425
Barbara SchmalfeldtDepartment of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Lars HankerDepartment of Obstetrics and Gynecology, University Medical Center Luebeck, 23562 Luebeck, Germany.
Markus WallwienerDepartment of Gynecology and Obstetrics, University of Heidelberg, 69120 Heidelberg, Germany.
Andreas SchneeweissNational Center for Tumor Diseases, University Hospital and German Cancer Research Center Heidelberg, 69120 Heidelberg, Germany.
Jalid SehouliDepartment of Gynecology, Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 13353 Berlin, Germany.ORCID 0000-0002-5963-6623
Klaus PietznerYoung Academy of Gynecologic Oncology (JAGO), 13359 Berlin, Germany.ORCID 0000-0003-2056-1668

Funding

Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie Paid costs for ethical vote
6 · The paper itself

Abstract

backgroundSurgery is the backbone of early-stage ovarian cancer (OC) management. However, in practice, there is disagreement about the extent of surgical staging and whether additional adjuvant treatment should be provided. As omitting relevant diagnostic or therapeutic procedures might lead to undertreatment, we aimed to structurally investigate treatment practice in addition to prognostic factors in a multicentre series of patients (pts) diagnosed with early-stage OC. PATIENTS: Within this retrospective, multicentre study, medical records of 379 pts who had undergone surgery for suspected early-stage OC between January 2014 and March 2020 were analysed.

resultsOf the 379 patients, 292 had pT stage 1a-2a and had complete data on the extent of surgical staging. At least one surgical step was omitted in 100 pts (34.2%). Complete surgical staging (

conclusionsThis study helps to increase our understanding of early-stage OC treatment and prognosis. In addition to treating patients in compliance with current guidelines, the need for

Indexed as

adjuvant treatmentBRCAearly-stage ovarian cancersurgery

Identifiers

PMID37046699
PMCPMC10093615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.